MRK News and Press, Merck & Company Inc.

2026-03-18 08:00:22 ET In the previous article, "GSK: Depemokimab and Jemperli Lead the Next Wave" , I talked primarily about Q3 earnings, the impact of the data from the Phase 2 study [ NCT04165772 ] on Jemperli's long-term prospects, and why, in my opinion, declining Zejula sa...

2026-03-18 07:39:09 ET More on Pfizer, Merck, etc. Expect Pfizer To Comeback: Take The Dividend While Waiting For Capital Appreciation Eli Lilly Reaching For Peak GLP-1 Euphoria: Rotten Trading Momentum Since November Eli Lilly: The Weight-Loss Craze Isn't Over ...

2026-03-17 14:18:35 ET The last time I wrote about Spyre Therapeutics, Inc. ( SYRE ) it was in a Seeking Alpha article entitled " Spyre: Extended Half-Life Tech To Become Differentiating Factor For IBD Targeting ." With respect to this article, I mentioned that the company w...

Data show long-term effectiveness of GARDASIL ® 9 and GARDASIL ® 14 years and 18 years, respectively, following vaccination with 3 doses Data on certain HPV-related oropharyngeal cancers reinforce the importance of vaccination for both females and males Merck...

2026-03-17 05:12:01 ET ... Read the full article on Seeking Alpha For further details see: PJP: Healthcare Dashboard For March

2026-03-16 17:46:50 ET More on pharma companies GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Need Growing EPS And Dividends? Prescribe Sanofi Merck & Co., Inc. (MRK) Presents at TD Cowen 46th Annual Health Care Conference...

Late-breaking presentation of results from the Phase 3 CORALreef AddOn trial evaluating enlicitide decanoate, Merck’s investigational oral PCSK9 inhibitor, which may help address the cardiovascular (CV) epidemic Data from the Phase 2 CADENCE trial of WINREVAIR TM (sotatercept-c...

2026-03-15 23:25:00 ET The following segment was excerpted from the PGIM Jennison Health Sciences Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: PGIM Jennison Health Sciences Fund Q4 2025 Key ...

2026-03-14 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

2026-03-13 17:01:42 ET Investment Thesis Conventional wisdom seems to have ruled out Pfizer Inc. ( PFE ) as it trades for only 8–9× forward earnings, but there are good reasons to believe it will make a comeback. Trading between $25 and $30 since 2022, it could s...